SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023659
Filing Date
2016-08-09
Accepted
2016-08-09 16:06:26
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mstx-10q_20160630.htm 10-Q 1292069
2 EX-31.1 mstx-ex311_9.htm EX-31.1 16093
3 EX-31.2 mstx-ex312_10.htm EX-31.2 16145
4 EX-32.1 mstx-ex321_7.htm EX-32.1 10775
  Complete submission text file 0001564590-16-023659.txt   4151809

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mstx-20160630.xml EX-101.INS 716172
6 XBRL TAXONOMY EXTENSION SCHEMA mstx-20160630.xsd EX-101.SCH 39987
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20160630_cal.xml EX-101.CAL 29257
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20160630_def.xml EX-101.DEF 102297
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20160630_lab.xml EX-101.LAB 258027
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20160630_pre.xml EX-101.PRE 205968
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 161817903
SIC: 2834 Pharmaceutical Preparations